Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a public offering price of $12.00 per share.
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, announced that two abstracts have been accepted for poster presentations at the European Association for the Study of the Liver Congress 2023 taking place June 21 – 24, 2023 in Vienna, Austria.
Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023 Read More »
El cambio climático es uno de los desafíos más urgentes que enfrenta nuestro planeta en la actualidad. A medida que las emisiones de dióxido de carbono (CO2) continúan aumentando, la necesidad de encontrar formas efectivas de extraer CO2 de la atmósfera se v …
Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces it will host a Key Opinion Leader webinar on Proof-of-Concept Phase 2a study preliminary results of SENS-401 for residual hearing preservation following cochlear implantation.
ITabMed Ltd., a clinical-stage biotech company in China, announced the IND approval from China National Medical Products Administration for A-337, a CD3-activating bi-specific antibody targeting EpCAM.
While the company’s new chief commercial officer and its recently appointed CEO “have a considerable amount of experience,” Nevro still faces challenges in its core market, according to analysts.
Unos científicos proponen un modo más robusto de conectar bits cuánticos usando luz topológica. Los materiales topológicos son más resistentes ante las imperfecciones y pueden ayudar en la construcción de chips más robustos para computadoras cu …
Los impuestos sobre el carbono incrementan el coste de los productos a los que se aplican, con el objetivo de reducir su consumo. Pero, ¿realmente se consigue este efecto? En un estudio reciente se ha buscado aclarar esta cuestión. En la Facultad de Economía y Empresa d …
Mostrar la tasa de carbono en los productos ¿disuade o incentiva su compra? Read More »
The DNA-sequencing company that has been fighting regulators over orders to reverse its 2021 acquisition of Grail is accusing the U.S. government of overreach and collusion with European regulators.
Illumina appeals FTC’s order to divest Grail with plea for cancer screening test Read More »
The drugmaker’s lawsuit claims the new pricing powers granted by the Inflation Reduction Act are unconstitutional and “tantamount to extortion.”
Merck sues to stop Medicare negotiation of drug prices Read More »
